Skip to main content
Clinical Trials/DRKS00023438
DRKS00023438
Completed
Not Applicable

Influence of non-invasive positive pressure ventilation versus nasal high-frequency oscillation ventilation on parameters of oxygenation and ventilation in premature infants in the weaning phase after respiratory distress syndrome

Menschen für Kinder e.V.0 sites24 target enrollmentMay 11, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
P22.0
Sponsor
Menschen für Kinder e.V.
Enrollment
24
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 11, 2021
End Date
October 7, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Menschen für Kinder e.V.

Eligibility Criteria

Inclusion Criteria

  • 1\. Premature babies with a gestational age \<32 weeks of gestation and a birth weight \<1500 g, who are treated in the neonatal intensive care unit of the University Hospital Giessen and are at least 72 hours old.
  • 2\. Requirement of non\-invasive ventilation (CPAP / NIPPV.
  • 3\. FiO2 under CPAP / NIPPV 21 % \- 60% with a PEEP of 5\-8 cmH20
  • 4\. At least 4 hypoxemias (\<80% SpO2\) and / or apneas / bradycardias in the 12 hours prior to study entry.
  • 5\. In the 12 hours prior to study entry, the number of intervention\-requiring events (defined as SpO2 \<70% for\> 1min or heart rate \<100 / min for\> 30 seconds) does not lead to an escalation of the non\-invasive ventilation.
  • 6\. Written consent of the legal guardian is given.

Exclusion Criteria

  • 1\. Premature babies and newborns with severe malformations that significantly impair respiratory regulation (severe CNS malformations), lung function (e.g. pulmonary hypoplasia, acute extra\-alveolar air such as pneumothorax and pulmonary interstitial emphysema, diaphragmatic hernias) or the circulatory function (congenital cyanotic heart disease, septic shock).
  • 2\. Postnatal age \<72 hours of life (often acute deterioration in the early phase of a respiratory distress syndrome and to protect the minimal handling principle in the critical phase to prevent intraventricular bleeding).
  • 3\. Start of treatment for an acute clinical infection \<72 hours before study entry.
  • 4\. FiO2 under CPAP / NIPPV\> 60% and / or PEEP\> 8cmH20\.
  • 5\. Escalation of non\-invasive ventilation in the 12 hours before study entry due to the number of intervention\-requiring events (defined as SpO2 \<70% for\> 1 min. or Heart rate \<100 / min. for\> 30 seconds).
  • 6\. Planned blood transfusion or surgery during the study phase.

Outcomes

Primary Outcomes

Not specified

Similar Trials